Indirubin-3′-oxime is primarily investigated for its potential therapeutic applications, particularly in the field of cancer research. It has shown promise as an inhibitor of cyclin-dependent kinases (CDKs), which are crucial regulators of cell cycle progression. By targeting these kinases, it may help in arresting the growth of cancer cells, making it a candidate for anticancer drug development. Additionally, it has been studied for its anti-inflammatory properties, which could be beneficial in treating chronic inflammatory diseases. Research also explores its role in neurodegenerative conditions, where it might help in modulating pathways involved in cell survival and death. Overall, Indirubin-3′-oxime is a compound of interest in developing treatments for various complex diseases.